Compumedics Ltd
Compumedics Limited is an Australia-based medical device company which is involved in the development, manufacture, and commercialization of diagnostics technology for sleep, brain and ultrasonic blood flow monitoring applications.
The business
Compumedics Limited is an Australia-based medical device company which is involved in the development, manufacture, and commercialization of diagnostics technology for sleep, brain and ultrasonic blood flow monitoring applications. Its geographic segments include the Americas, Australia and Asia Pacific, and Europe and the Middle East. It sells all of its product offerings in this region, including sleep diagnostic systems, clinical electroencephalograms (EEG systems), brain monitoring systems, ultrasonic blood-flow systems, supplies and technical service and support. It provides Sleep Diagnostics and Neurology Diagnostics Solutions. Its products include Compumedics Siesta, Compumedics Somfit, Compumedics Somte PSG and others. It provides a range of solutions for the neurology laboratory, from clinical epilepsy monitoring applications to Transcranial Doppler Sonography. Its other products include Grael 4K PSG, Falcon HST, Okti, Neuvo 64-512 Channel LTM EEG and others.
Share price
Market Statistics
Valuation
Trading Activity
Performance
Latest news
Compumedics Delivers Record FY26 Revenue as SaaS Growth Accelerates
Compumedics posts FY26 revenue of $60.3m (+18%), SaaS up ~70% led by Somfit/Nexus 360; MEG delays temper guidance, FY27 targets double-digit growth.
Compumedics Looks to Turn the Corner after Record Sales And Growth in FY25
Compumedics (ASX: CMP) has marked a strategic turning point in its development after posting record sales and profitable growth for the 2025 financial year. The company racked up $63.4 million in sales for the period, representing a growth of 22% on the previous year. Its EBITDA increased to approximately $3m, returning Compumedics to profitability and […]
Compumedics reaches $20m in Chinese MEG sales with latest university contract
Brain research technologies specialist Compumedics (ASX: CMP) has reached $20 million in sales for its magnetoencephalography (MEG) system in China. The latest $5.7m contract from Hangzhou Normal University follows the successful installation of a MEG system at Tianjin Normal University and further orders from Tsinghua and Tianjin universities. MEG is a neuroimaging technique for mapping […]
Compumedics eyes US market with Somfit sleep diagnostic device
Brain research technology specialist Compumedics (ASX: CMP) has achieved a major breakthrough with the planned distribution of its Somfit sleep assist system, with the Food & Drug Administration (FDA) clearing the device to be marketed in the United States. Compumedics is targeting the multi-million dollar sleep market in the US with the Somfit technology, which […]
Looking for charts & signals? See the tab.
Unlock the full research library - free.
Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.